• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Fecal occult-blood testing linked with reduction in colorectal-cancer mortality

bys25qthea
September 18, 2013
in Chronic Disease, Gastroenterology, Oncology
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. Across a 30-year follow-up period, annual and biennial fecal occult-blood testing groups had a risk of death from colorectal cancer that was 32% and 22% lower, respectively, than that of unscreened controls. 

2. There was no reduction in all-cause mortality between the combined screening groups and the control group. 

Evidence Rating Level: 1 (Excellent) 

Study Rundown: In this randomized control study, the authors followed a large cohort of healthy volunteers across a 30-year follow-up period and showed that the annual and biennial fecal occult-blood testing (FOBT) groups had a risk of death from colorectal cancer that was 32% and 22% lower, respectively, than that of unscreened controls.  Men between 60 to 69 years of age benefited the most, while no significant benefits of screening were found among women less than 60 years of age.  Despite the large sample size, the authors did not observe any reduction or trend toward a reduction in all-cause mortality between the screening groups and the control group.

This study provides grounding for the continued use of fecal occult-blood testing along with colonoscopy for colorectal-cancer screening, in keeping with current colorectal-cancer screening guidelines.  Randomized trials are ongoing to compare directly between FOBT and colonoscopy, but prior research has shown that FOBT offered in conjunction with colonoscopy can increase rates of colorectal-cancer screening.  Furthermore, advances in FOBT technology, including the fecal immunochemical test (FIT) have made this a more desirable screening platform.  Strengths of this study include the large sample size and the observation of a colorectal-cancer mortality reduction that was consistent across a 30-year study period.  This latter finding was suggestive of the effect of removing adenomas presumably found after FOBT screening that would have progressed to cancer and death.

A notable drawback of the study was that information on vital status and cause of death was collected from death certificates, with a substantial interval between time of death and availability of the information.  Further, there were no data regarding the screening history of trial participants after the original trial ended, so the result measures include the effect of unknown screening behaviors in the interim period.

RELATED REPORTS

Same appointment mammogram results may result in less stress for patients being screened for breast cancer

Ovarian cancer screening does not reduce mortality [Classics Series]

Breast, colorectal, and cervical cancer screening was reduced during the COVID-19 pandemic as compared to pre-COVID time periods.

Click to read the study, published today in NEJM

Click to read an accompanying editorial in NEJM

Relevant Reading: Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes?

In-Depth [randomized, controlled trial]: This study randomized 46,551 healthy volunteers, aged 50 to 80 years, to three groups: annual or biennial screening with FOBT, or usual care (control).  The primary end point was colorectal-cancer mortality.  Screening took place between 1976 and 1992, with a 4-year hiatus from 1982 to 1986. Individuals found to have a positive FOBT underwent typical diagnostic workup including colonoscopy with polypectomy if necessary (complication incidence 0.1%).  90% of participants completed at least one FOBT, and the follow-up rate for positive tests was 83%.  In 2011, mortality end points after 30 years of follow-up were assigned through a National Death Index database search in order to determine the cause of death as colorectal-cancer related or other.

After 30 years of follow-up, there were 33,020 deaths in total. Those specifically attributed to colorectal cancer were 1.8%, 2.2%, and 2.7% of deaths in the annual-screening, biennial-screening, and control groups respectively.  The relative risk of death from colorectal cancer was 0.68 (95% CI, 0.56 to 0.82) with annual screening and 0.78 (95% CI, 0.65-0.93) with biennial screening.  Annual or biennial screening with FOBT did not have a significant effect on all-cause mortality; the relative risk of death from any cause was 1.00 (95% CI, 0.99 to 1.01) with annual screening and 0.99 (95% CI, 0.98 to 1.01) with biennial screening.  In subgroup analysis, the reduction in colorectal-cancer mortality was larger for men than for women in both screening groups. The interaction between sex and screening, measured by the ratio of the relative risk for men to that of women, was significant in the biennial screening group (P=0.04 for interaction).  There was no benefit to screening among women less than 60 years of age.

By Matthew Growdon and Adrienne Cheung

More from this author: Alternative treatment for acute promyelocytic leukemia promising, The CHEST-1 & PATENT-1: Riociguat significantly improves exercise capacity in pulmonary hypertension patients, High glucose levels associated with increased risk of dementia, Insecticidal bed nets linked with reduced transmission of lymphatic filariasis

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: cancer screeningcolon cancer
Previous Post

Medicaid beneficiaries among most frequent visitors to the emergency department

Next Post

RSV positivity associated with reduced serious bacterial infection risk [Classics Series]

RelatedReports

Breast cancer chemoprevention may reduce mortality in lobular carcinoma-in-situ
Oncology

Same appointment mammogram results may result in less stress for patients being screened for breast cancer

August 19, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Radiology Classics

Ovarian cancer screening does not reduce mortality [Classics Series]

August 12, 2022
Patient Basics: Colonoscopy
Oncology

Breast, colorectal, and cervical cancer screening was reduced during the COVID-19 pandemic as compared to pre-COVID time periods.

July 18, 2022
Chronic Disease

COVID-19 pandemic associated with reductions in delivery of cancer care services in Ontario, Canada

April 29, 2022
Next Post
Classics Series, Landmark Trials in Medicine

RSV positivity associated with reduced serious bacterial infection risk [Classics Series]

Reminder intervention increases colorectal cancer screening rates

Prospective analysis supports current colorectal cancer screening guidelines

Outer glove exchange and paper surgical gowns decrease bacterial contamination

Outer glove exchange and paper surgical gowns decrease bacterial contamination

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
  • High-protein supplementation improves linear growth in infants
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options